Reading up on Science with our partner Mercodia

Our partner Mercodia is a world-leading developer, manufacturer and distributor of high quality immunoassay kits. They would like to help you make the most of your time, especially with the current situation in the world. Have a look at some of their topics below!

Glucagon based therapy

Are you interested in glucagon-based therapies? This review summarizes the recent progress to comprehend glucagon-mediated pleiotropic effects, provides an overview of drug candidates currently being developed and discusses future perspectives in this research domain.


Virtual meetings

We know that many of you were planning to attend conferences that because of the COVID-19 pandemic has been cancelled. However, many organizers have sought other solutions, and one is ENDO Online 2020, on June 8 to 22. It will feature a mixture of on-demand and live programming with the latest information within the field of endocrinology.

Complimentary registration »»

Glicentin’s new potential

Two recently published studies show a novel potential for glicentin as a biomarker predicting weight loss after bariatric surgery. The studies find that enhanced postprandial glicentin levels early after bariatric surgery correlates with amount of weight loss 12 and 18 months after surgery, suggesting glicentin to be potential biomarker in these patients.


COVID-19 resources

We love how American Physiological Society has collected journal articles, resources, news articles and other information about COVID-19 to keep you informed and help you work smarter and more efficiently from home!